González Martínez Héctor Manuel

González Martínez Héctor Manuel
Ubicación: 
Módulo E
Teléfono: 
31342222
Areas de Investigación: 
Farmacobiologìa
Correo electrónico: 
hgonzalez@udgserv.cencar.udg.mx

1. “Combinatorial gene therapy induces regression of hepatic Encephalopathy”, Gene Therapy 18, 88–94; 2011 2. “Prevalence of CYP2C19 and CYP3A4 in Poor Metabolizers among inhabitants of Tlaxcala, Mexico” Proc. Western Pharmacol. Soc. 49: 102-103 2006 3. “Metabolism of Omeprazole after Two Oral Doses in Children 1 to 9 Months Old” Proc. Western Pharmacol. Soc. 48: 108-109 2005 4. “CYP2C19 and CYP3A4- Dependent Omeprazole Metabolism in West Mexicans”; J. Clin. Pharmacol.; 43 (11): 1211-5; 2003 5. “Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two man metabolites in plasma using liquid chromatography with liquid-liquid extraction”; J. Chromatogr. B; 25; 780(2) 459-465; 2002